METTL3-induced m6A modification increases the stability of Sec62 mRNA and upregulates Sec62 expression, which maintains the stem cell-like phenotype and chemotherapy resistance in CRC (Liu et al. 2021). This evidence concerns the gene SEC62 and colorectal carcinoma.